RheaVita develops continuous freeze-drying technology that integrates all process steps into a streamlined production line, ensuring constant infeed and outfeed of biopharmaceutical products. This approach reduces cycle times, minimizes production costs, and guarantees 100% product quality through real-time inspection, addressing the challenges of scale-up and manufacturing efficiency in the biopharmaceutical industry.
Funding
$3.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NBPFounders
Product
Problem
Traditional batch freeze-drying processes in biopharmaceutical manufacturing face challenges in scalability, long cycle times, high production costs, and ensuring consistent product quality. These inefficiencies hinder fast product development and time-to-market for biopharmaceutical products.
Solution
RheaVita offers continuous freeze-drying technology that integrates all process steps into a streamlined production line, ensuring constant infeed and outfeed of biopharmaceutical products. This continuous manufacturing approach reduces cycle times, lowers production costs, and improves product quality through real-time inspection. The technology avoids scale-up issues associated with batch processing, allows for faster product development, and requires smaller manufacturing installations with less clean room space. RheaVita provides single vial continuous freeze-drying systems for R&D settings and is developing systems for GMP production and non-GMP multi-vial processing.
Target Audience
The primary customers are biopharmaceutical companies and research institutions seeking to improve the efficiency, scalability, and quality control of their freeze-drying processes.
Features
- Continuous production line integrating all freeze-drying process steps
- Real-time inspection for 100% product quality assurance
- Reduced cycle times compared to traditional batch freeze-drying
- Smaller manufacturing installations requiring less clean room space
- Process Analytical Technologies (PAT) integration for enhanced process monitoring and control
- Single vial continuous freeze-drying systems for R&D
- Systems in development for GMP production and non-GMP multi-vial processing